# fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP or Placebo

> **NCT00156000** · — · WITHDRAWN · sponsor: **Obstetrix Medical Group**

## Conditions studied

- Preterm Delivery
- Preterm Birth

## Interventions

- **DEVICE:** Fetal Fibronectin
- **DEVICE:** Salivary Estriol

## Key facts

- **NCT ID:** NCT00156000
- **Lead sponsor:** Obstetrix Medical Group
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-08
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was stopped because of insufficient enrollment.
- **Last updated:** 2014-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156000, "fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP or Placebo". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00156000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*